In Utero DMD Therapy Was Unsuccessful in Murine Models
Alexas_Fotos / Pixabay

In Utero DMD Therapy Was Unsuccessful in Murine Models

The current standards-of-care for those with Duchenne muscular dystrophy (DMD) include corticosteroids, immunosuppressive treatments, physical therapy, and occupational therapy (among others). Gene therapy has the potential to change the treatment…

Continue Reading In Utero DMD Therapy Was Unsuccessful in Murine Models
PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer
mohamed_hassan / Pixabay

PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

Are there therapeutic options for patients living with unresectable (inoperable) pancreatic cancer? According to an article in MedScape, researchers sought to understand whether sunitinib or a combination of peptide receptor…

Continue Reading PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer
Positive Phase 1 Data Available on Sebetralstat for HAE
Photo courtesy of Towfiqu Barbhuiya on Unsplash

Positive Phase 1 Data Available on Sebetralstat for HAE

  According to a late October 2022 news release from pharmaceutical company KalVista Pharmaceuticals, Inc. (“KalVista”), the company released positive data from a Phase 1 study evaluating oral sebetralstat for…

Continue Reading Positive Phase 1 Data Available on Sebetralstat for HAE
First-Line Nivolumab Shows Significant Promise for Patients with cSCC
https://unsplash.com/photos/G6wVoIJY-iI

First-Line Nivolumab Shows Significant Promise for Patients with cSCC

Both Libtayo (cemiplimab) and Keytruda (pembrolizumab) have been shown to be beneficial treatment options for patients with locally advanced or metastatic cutaneous squamous cell carcinoma (cSCC). But could Opdivo (nivolumab)…

Continue Reading First-Line Nivolumab Shows Significant Promise for Patients with cSCC
IVIG Improved Dermatomyositis Symptoms, Study Says
Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

IVIG Improved Dermatomyositis Symptoms, Study Says

Currently, there are a number of therapies which can be used to treat individuals with dermatomyositis: corticosteroids, immunosuppressive agents, intravenous immune globulin (IVIG). Typically, corticosteroids are considered a first-line treatment,…

Continue Reading IVIG Improved Dermatomyositis Symptoms, Study Says
Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation
https://pixabay.com/en/toddler-boy-sleeping-child-1245674/

Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation

  In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to treat, diagnose, or prevent rare diseases or conditions. A rare disease is one…

Continue Reading Serdexmethylphenidate for Idiopathic Hypersomnia Earns Orphan Drug Designation